Abstract
Objective To explore the clinical effect of sometostatin in the treatment of severe acute pancreatitis and its influence on the level of TNF-α.Methods 68 cases with severe acute pancreatitis were randomly divided into two groups,34 cases in the control group were received general treatment,34 cases in the observation group were given sometostatin on the basi of general treatment for 5 ～ 7 days.The clinical effects and clinical indexes were observed and compared between the two groups.Results After treatment for 3 days,the level of TNF-α in the observation group was significantly lower than that in the control group( P ＜0.05 ),and the observation group patients recovered rapidly.The recovery time of blood amylase and intestinal function,hospital stay days,incidence of complications and mortality in the observation group were significantly shorter than those in the control group ( P ＜ 0.05 ).Conclusion Sometostatin is effective for treatment of severe acute pancreatitis,can decrease the level of TNF-α significantly,shorten disease course and improve the prognosis,which is good for clinical application. Key words: Pancreatitis; Sometostatin; TNF-α
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
